For The Better

The SEC opened a five-year test lane for blockchain stock trading. Most investors can watch this experiment from the sidelines for now.

Although rather deep in the red early on in today’s action, this tech stock is now well up after investors opted to see the glass as half-full rather than half-empty.

This overlooked ETF has been the best-performing broad-market Vanguard ETF over the past five years.

The mREIT pays a high yield, but its stock price is declining.

Oracle’s AI business is booming. The question is whether its cash flow can catch up with its spending.

The company could enter a fresh growth phase.

The director’s open-market purchase increased his direct stake by 67%, signaling confidence despite the stock’s -11% one-year return.

Many investors raised their eyebrows in skepticism when BYD said it could catch top-selling global automaker Toyota in volume, but its market share gains in Europe are impressive.

Michael Burry of “The Big Short” is bearish on artificial intelligence (AI) stocks.

The core Personal Consumption Expenditures (PCE) price index rose 0.2% in August, less than economists expected.

The cancer blood test maker could have a bright future.

SpaceX reached a major milestone just this week.

The Nasdaq gained 1.1% by mid-day today. The Dow went exactly nowhere.

There is probably no dividend cut on the horizon for these healthcare companies.

The pharmaceutical giant still looks like a stable long-term investment.

The fast-growing industry is at an early stage of what it could be.

The social media giant’s stock has the potential to nearly triple in the next five years.

Today, Sept. 30, 2026, softer PCE growth is supporting sentiment amid heightened single-stock volatility.

The chances of rate hike at the Fed’s next meeting just fell significantly.